Search Results - "Symons, Jori"
-
1
Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance
Published in Nature communications (13-07-2021)“…The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously…”
Get full text
Journal Article -
2
HIV integration sites in latently infected cell lines: evidence of ongoing replication
Published in Retrovirology (13-01-2017)“…Assessing the location and frequency of HIV integration sites in latently infected cells can potentially inform our understanding of how HIV persists during…”
Get full text
Journal Article -
3
Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART
Published in PLoS pathogens (19-01-2021)“…The precise role of CD4 T cell turnover in maintaining HIV persistence during antiretroviral therapy (ART) has not yet been well characterized. In resting CD4…”
Get full text
Journal Article -
4
Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial
Published in PloS one (24-07-2015)“…The immunomodulatory effects of the CCR5-antagonist maraviroc might be beneficial in patients with a suboptimal immunological response, but results of…”
Get full text
Journal Article -
5
HIV population genotypic tropism testing and its clinical significance
Published in Current opinion in HIV & AIDS (01-09-2012)“…PURPOSE OF REVIEWHIV co-receptor tropism testing is recommended before therapy when the C-C chemokine receptor type 5 antagonist maraviroc is initiated. This…”
Get full text
Journal Article -
6
Erratum to: HIV integration sites in latently infected cell lines: evidence of ongoing replication
Published in Retrovirology (27-03-2017)“…In the original publication [1] the spelling of one author name was incorrect. The correct version: Eva Malatinkova…”
Get full text
Journal Article -
7
HIV-1 Reverse Transcriptase Connection Domain Mutations: Dynamics of Emergence and Implications for Success of Combination Antiretroviral Therapy
Published in Clinical infectious diseases (01-09-2010)“…Background. Factors promoting the emergence of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) connection domain mutations and their…”
Get full text
Journal Article -
8
Improved single-chain transactivators of the Tet-On gene expression system
Published in BMC biotechnology (19-01-2007)“…The Tet-Off (tTA) and Tet-On (rtTA) regulatory systems are widely applied to control gene expression in eukaryotes. Both systems are based on the Tet repressor…”
Get full text
Journal Article -
9
In Vivo T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design
Published in ACS nano (23-03-2021)“…T cells play an important role in immunity and repair and are implicated in diseases, including blood cancers, viral infections, and inflammation, making them…”
Get full text
Journal Article -
10
HIV integration sites and implications for maintenance of the reservoir
Published in Current opinion in HIV & AIDS (01-03-2018)“…PURPOSE OF REVIEWTo provide an overview of recent research of how HIV integration relates to productive and latent infection and implications for cure…”
Get full text
Journal Article -
11
Shock and kill within the CNS: A promising HIV eradication approach?
Published in Journal of leukocyte biology (01-11-2022)“…The most studied HIV eradication approach is the “shock and kill” strategy, which aims to reactivate the latent reservoir by latency reversing agents (LRAs)…”
Get full text
Journal Article -
12
CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4 + T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and Maintained
Published in Journal of virology (28-02-2020)“…HIV can persist in people living with HIV (PLWH) on antiretroviral therapy (ART) in multiple CD4 T cell subsets, including naive cells, central memory (CM)…”
Get full text
Journal Article -
13
Persistence of envelopes in different CD4 + T-cell subsets in antiretroviral therapy-suppressed people with HIV
Published in AIDS (London) (01-02-2023)“…Despite suppressive antiretroviral therapy (ART), HIV can persist in a diverse range of CD4+ T-cell subsets. Through longitudinal env sampling from people with…”
Get full text
Journal Article -
14
Acoustofection: High-Frequency Vibrational Membrane Permeabilization for Intracellular siRNA Delivery into Nonadherent Cells
Published in ACS applied bio materials (15-03-2021)“…The internalization of therapeutic molecules into cellsa critical step in enabling a suite of autologous ex vivo gene and cell therapiesis highly regulated…”
Get full text
Journal Article -
15
Nanoscale probing and imaging of HIV-1 RNA in cells with a chimeric LNA-DNA sensor
Published in Nanoscale (24-02-2022)“…Real-time detection and nanoscale imaging of human immunodeficiency virus type 1 ribonucleic acid (HIV-1 RNA) in latently infected cells that persist in people…”
Get more information
Journal Article -
16
Neurotoxicity with high dose disulfiram and vorinostat used for HIV latency reversal
Published in AIDS (London) (29-09-2021)Get full text
Journal Article -
17
Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection
Published in AIDS (London) (01-12-2023)“…People with HIV rarely control viral replication after cessation of antiretroviral therapy (ART). We present a person with HIV with extraordinary posttreatment…”
Get full text
Journal Article -
18
Dependence on the CCR5 Coreceptor for Viral Replication Explains the Lack of Rebound of CXCR4-Predicted HIV Variants in the Berlin Patient
Published in Clinical infectious diseases (15-08-2014)“…The "Berlin patient" is the first patient cured of HIV-1 infection after allogeneic transplantation with nonfunctional CCR5 coreceptor stem cells. We…”
Get full text
Journal Article -
19
Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal
Published in AIDS (London) (01-01-2022)“…The aim of this study was to examine whether administering both vorinostat and disulfiram to people with HIV (PWH) on antiretroviral therapy (ART) is well…”
Get full text
Journal Article -
20
De novo design of CRISPR-Cas13b enables efficient silencing of SARS-CoV-2 variants and tumour pathogenic RNAs with near single-base precision
Published in Pathology (01-03-2022)Get full text
Journal Article